Pregnancy outcome in four women with inflammatory bowel disease treated with budesonide MMX
暂无分享,去创建一个
[1] B. Nørgård,et al. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease , 2017, Inflammatory bowel diseases.
[2] H. Tilg,et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management , 2017, Journal of Crohn's & colitis.
[3] C. Chambers,et al. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease. , 2017, Gastroenterology.
[4] T. Molnár,et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. , 2017, Journal of Crohn's & colitis.
[5] M. Julsgaard. Adherence to medical treatment in relation to pregnancy, birth outcome & breastfeeding behavior among women with Crohn's disease. , 2016, Danish medical journal.
[6] A. Bitton,et al. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. , 2016, Gastroenterology.
[7] Sheridan M. Hoy. Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis , 2015, Drugs.
[8] C. J. van der Woude,et al. Does lower gastrointestinal endoscopy during pregnancy pose a risk for mother and child? – a systematic review , 2015, BMC Gastroenterology.
[9] C. J. van der Woude,et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. , 2015, Journal of Crohn's & colitis.
[10] Christopher F. Martin,et al. 1 Achievement of Developmental Milestones Among Offspring of Women With Inflammatory Bowel Disease: The PIANO Registry , 2014 .
[11] P. Lakatos,et al. The burden of inflammatory bowel disease in Europe. , 2013, Journal of Crohn's & colitis.
[12] S. Travis,et al. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study , 2013, Gut.
[13] M. Nørgaard,et al. Self‐reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis , 2011, Inflammatory bowel diseases.
[14] A. Hviid,et al. Corticosteroid use during pregnancy and risk of orofacial clefts , 2011, Canadian Medical Association Journal.
[15] M. Nørgaard,et al. Self‐reported antenatal adherence to medical treatment among pregnant women with Crohn’s disease , 2010, Alimentary pharmacology & therapeutics.
[16] F. Nagy,et al. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. , 2010, Journal of Crohn's & colitis.
[17] Dawn B. Beaulieu,et al. Budesonide induction and maintenance therapy for Crohn's disease during pregnancy , 2009, Inflammatory bowel diseases.